Contrast Media/Contrast Agent Market by Type (Iodinated, Gadolinium, Barium, & Microbubble), Procedure (X-Ray/CT, MRI, & Ultrasound) & Application (Radiology, Interventional Radiology, & Interventional Cardiology) - Global Forecasts to 2021

造影剤の世界市場予測(~2021年):ヨード系造影剤、ガドリニウム造影剤、バリウム造影剤、マイクロバブル

◆タイトル:Contrast Media/Contrast Agent Market by Type (Iodinated, Gadolinium, Barium, & Microbubble), Procedure (X-Ray/CT, MRI, & Ultrasound) & Application (Radiology, Interventional Radiology, & Interventional Cardiology) - Global Forecasts to 2021
◆商品コード:MAM-MD-3577
◆調査・発行会社:MarketsandMarkets
◆発行日:2016年10月19日
◆ページ数:162
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、造影剤の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、処置別分析、用途別分析、地域別分析、造影剤の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・造影剤の世界市場:市場インサイト
・造影剤の世界市場:市場概観/市場動向
・造影剤の世界市場:市場シェア分析
・造影剤の世界市場:種類別分析/市場規模
・造影剤の世界市場:処置別分析/市場規模
・造影剤の世界市場:用途別分析/市場規模
・造影剤の世界市場:地域別分析/市場規模
・造影剤のアジア市場規模予測
・造影剤のヨーロッパ市場規模予測
・造影剤のアメリカ市場規模予測
・造影剤の世界市場動向
・造影剤の世界市場:競争状況
・造影剤の世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

The global contrast agents/contrast media market is projected to reach USD 5.44 Billion by 2021 from USD 4.46 Billion in 2016 growing at a CAGR of 4.1% during the forecast period. This growth can be attributed to factors such as increasing approvals for contrast agents and increase in the number of public and private diagnostic centers to improve diagnostic imaging services are driving the demand of various diagnostic imaging modalities. Moreover, strong product pipelines of the market players, coupled with the increasing research studies regarding applications of various contrast agents, are expected to drive the market in the near future.
The market has been segmented on the basis of type, procedure, indication, route of administration, application, and region. Based on route of administration, the overall market has been segmented into oral, injectable, rectal, and urethral routes. The injectable segment is expected to account for the largest share of the market, among the different routes of administration. The large share of this segment can be attributed to advancements in CT and MRI imaging technologies, which majorly use injectable contrast media.

Based on indication, the market is segmented into cardiovascular disorders, oncology, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is estimated to account for the largest share of the global market, by indication in 2016. Improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies for contrast media used in cardiovascular diagnosis, and strong healthcare infrastructure in countries like the U.S., Canada, the U.K., and Germany are some of the factors driving the growth of this segment.

Based on procedure, the global contrast media market is segmented into X-ray/CT, MRI, and ultrasound. The X-ray/CT segment is expected to account for the largest share of the market, among the procedures in 2016. However, the ultrasound segment is expected to register the highest CAGR during the forecast period. Development of microbubble contrast media for ultrasound, large number of approvals for ultrasound contrast media in the U.S., Europe, and Japan are some of the major factors driving the growth of this segment.

Based on application, the global market is segmented into radiology, interventional radiology, and interventional cardiology. The radiology segment is expected to account for the largest share of the market, among the applications in 2016. The large share of this segment can be attributed to the growing number of diagnostic procedures/centers coupled with the increasing disease burden on countries.

Based on region, the global market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is estimated to account for the largest share, followed by Europe and Asia-Pacific. However, the European market is expected to grow at the highest CAGR during the forecast period, and will also serve as a revenue pocket for companies offering contrast media/contrast agents in the near future. The high growth in this region can be attributed to the increasing research & development investments by market players, increasing incidence and prevalence of cancer, and increasing number of MRI and CT scanners.

The prominent players in the global market include Bayer HealthCare (Germany), GE Healthcare (U.S.), Guerbet Group (France), and Bracco Imaging S.p.A. (Italy). These companies are dominant in the contrast agents/contrast media market mainly due to their well-established presence in the field of genomics, presence in over 50 countries, high R&D investments, and strong sales and distribution force. Other players operating in this market include Lantheus Medical Imaging (U.S.), nanoPET Pharma GmbH (Germany), CMC Contrast AB (Sweden) Daiichi Sankyo (Japan), and Subhra Pharma Private Limited (India).

【レポートの目次】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Insights From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Forecast Methodology
2.5 Market Data Validation and Triangulation
2.6 Assumptions

3 Executive Summary (Page No. – 28)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 32)
4.1 Contrast Media Market Overview
4.2 Contrast Media Market, By Type and Route of Administration (2016)
4.3 Geographic Snapshot: Contrast Media Market
4.4 Global Contrast Media Market, By Indication (2016 vs 2021)

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Large Number of Approvals for Contrast Agents
5.2.1.2 Increasing Number of Public and Private Diagnostic Centers
5.2.2 Restraint
5.2.2.1 Side Effects and Allergic Reactions Associated With Contrast Agents
5.2.3 Opportunity
5.2.3.1 Increasing Number of Research and Funding Activities for Contrast Agents
5.2.4 Challenges
5.2.4.1 Development of Gamma and Neutron Imaging Solutions
5.2.4.2 Need for Highly Skilled Professionals

6 Pipeline Assessment (Page No. – 44)
6.1 Introduction
6.1.1 Clinical Trials Using Contrast Media
6.1.2 Product Pipeline

7 Global Contrast Media Market, By Type (Page No. – 50)
7.1 Introduction
7.2 Iodinated Contrasts Media
7.3 Gadolinium-Based Contrasts Media
7.4 Microbubble Contrasts Media
7.5 Barium- Based Contrasts Media

8 Global Contrast Media Market, By Medical Procedure (Page No. – 57)
8.1 Introduction
8.2 X-Ray/CT
8.3 MRI
8.4 Ultrasound

9 Global Contrast Media Market, By Route of Administration (Page No. – 63)
9.1 Introduction
9.2 Injectable Contrasts Media
9.3 Oral Contrasts Media
9.4 Rectal Contrasts Media
9.5 Urethral Contrasts Media

10 Global Contrast Media Market, By Indication (Page No. – 70)
10.1 Introduction
10.2 Cardiovascular Disorders
10.3 Oncology
10.4 Gastrointestinal Disorders
10.5 Neurological Disorders
10.6 Nephrological Disorders
10.7 Musculoskeletal Disorders

11 Global Contrast Media Market, By Application (Page No. – 78)
11.1 Introduction
11.2 Radiology
11.3 Interventional Cardiology
11.4 Interventional Radiology

12 Contrast Media Market, By Region (Page No. – 83)
12.1 Introduction
12.2 North America
12.2.1 U.S.
12.2.1.1 Increasing Number of Diagnostic Imaging Tests and Centers
12.2.1.2 Rising Aging Population, Rising Prevalence of Chronic Diseases
12.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias
12.2.2 Canada
12.2.2.1 Rising Aging Population, High Incidence of Cancer, Cvd, and Diabetes
12.2.2.2 Increasing MRI and CT Examinations
12.2.2.3 Increasing Research Activities
12.3 Europe
12.3.1 Europe 5
12.3.1.1 Increase in Investments By Market Players
12.3.1.2 Increasing Incidence and Prevalence of Cancer
12.3.1.3 U.K.: Lack of Sufficient Instruments
12.3.1.4 Conferences/Meetings/Symposiums/Workshops in Europe
12.3.2 RoE
12.3.2.1 Increase Focus of Market Players on RoE Countries
12.4 Asia-Pacific
12.4.1 Rise in Aging Population and Cancer Incidence
12.4.2 Expansion of International Players in China and India
12.4.3 Increasing R&D Investments in China
12.4.4 Favorable Regulatory Changes in New Zealand and Australia
12.4.5 Increasing Research Activities in Asia-Pacific
12.5 Rest of the World
12.5.1 Latin America
12.5.2 The Middle East
12.5.3 Africa

13 Competitive Landscape (Page No. – 120)
13.1 Overview
13.2 Market Share Analysis
13.2.1 Bayer Healthcare
13.2.2 GE Healthcare
13.3 Competitive Scenario
13.3.1 Market Developments (Product Approvals)
13.3.2 Agreements, Collaborations, Contracts, and Partnerships
13.3.3 Expansions
13.3.4 Other Strategies

14 Company Profiles (Page No. – 127)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
14.1 Introduction
14.2 GE Healthcare
14.3 Bayer AG
14.4 Bracco Imaging S.P.A.
14.5 Guerbet Group
14.6 Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
14.7 Nanopet Pharma GmbH
14.8 CMC Contrast AB
14.9 Daiichi Sankyo
14.10 Subhra Pharma Private Limited
14.11 Spago Nanomedical AB

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

15 Appendix (Page No. – 149)
15.1 Discussion Guide
15.2 Other Developments
15.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
15.4 Introducing RT: Real-Time Market Intelligence
15.5 Available Customizations
15.6 Related Reports

List of Tables (77 Tables)

Table 1 Indicative List of Research Studies Undertaken By Research Institutes and Universities
Table 2 Indicative List of Clinical Trials Conducted for Contrast Media
Table 3 Indicative List of Product Pipeline for Contrast Media
Table 4 Market Size, By Type, 2014–2021 (USD Million)
Table 5 Iodinated Market Size, By Region, 2014–2021 (USD Million)
Table 6 Gadolinium-Based Market Size, By Region, 2014–2021 (USD Million)
Table 7 Microbubble Market Size, By Region, 2014–2021 (USD Million)
Table 8 Barium-Based Market Size, By Region, 2014–2021 (USD Million)
Table 9 Market Size, By Medical Procedure, 2014–2021 (USD Million)
Table 10 Market Size for X-Ray/CT Procedures, By Region, 2014–2021 (USD Million)
Table 11 Market Size for MRI Procedures, By Region, 2014–2021 (USD Million)
Table 12 Market Size for Ultrasound Procedures, By Region, 2014–2021 (USD Million)
Table 13 Market Size, By Route of Administration, 2014–2021 (USD Million)
Table 14 Injectable Market Size, By Region, 2014–2021 (USD Million)
Table 15 Oral Market Size, By Region, 2014–2021 (USD Million)
Table 16 Rectal Contrast Media Market Size, By Region, 2014–2021 (USD Million)
Table 17 Urethral Contrast Media Market Size, By Region, 2014–2021 (USD Million)
Table 18 Market Size, By Indication, 2014–2021 (USD Million)
Table 19 Market Size for Cardiovascular Disorders, By Region, 2014–2021 (USD Million)
Table 20 Market Size for Oncology, By Region, 2014–2021 (USD Million)
Table 21 Market Size for Gastrointestinal Disorders, By Region, 2014–2021 (USD Million)
Table 22 Market Size for Neurological Disorders, By Region, 2014–2021 (USD Million)
Table 23 Market Size for Nephrological Disorders, By Region, 2014–2021 (USD Million)
Table 24 Market Size for Musculoskeletal Disorders, By Region, 2014–2021 (USD Million)
Table 25 Market Size, By Application, 2014–2021 (USD Million)
Table 26 Market Size for Radiology, By Region, 2014–2021 (USD Million)
Table 27 Market Size for Interventional Cardiology, By Region, 2014–2021 (USD Million)
Table 28 Market Size for Interventional Radiology, By Region, 2014–2021 (USD Million)
Table 29 Market Size, By Region, 2014-2021 (USD Million)
Table 30 North America: Market Size, By Procedure, 2014-2021 (USD Million)
Table 31 North America: Market Size, By Type, 2014-2021 (USD Million)
Table 32 North America: Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 33 North America: Market Size, By Indication, 2014-2021 (USD Million)
Table 34 North America: Market Size, By Application, 2014-2021 (USD Million)
Table 35 U.S.: Market Size, By Procedure, 2014-2021 (USD Million)
Table 36 U.S.: Market Size, By Type, 2014-2021 (USD Million)
Table 37 U.S.: Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 38 U.S.: Market Size, By Indication, 2014-2021 (USD Million)
Table 39 U.S.: Market Size, By Application, 2014-2021 (USD Million)
Table 40 Research Projects in Canada, 2013–2016
Table 41 Canada: Market Size, By Procedure, 2014-2021 (USD Million)
Table 42 Canada: Market Size, By Type, 2014–2021 (USD Million)
Table 43 Canada: Contrast Media Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 44 Canada: Contrast Media Market Size, By Indication, 2014-2021 (USD Million)
Table 45 Canada: Contrast Media Market Size, By Application, 2014-2021 (USD Million)
Table 46 Europe: Contrast Media Market Size, By Country, 2014-2021 (USD Million)
Table 47 Europe: Contrast Media Market Size, By Procedure, 2014-2021 (USD Million)
Table 48 Europe: Contrast Agents Market Size, By Type, 2014-2021 (USD Million)
Table 49 Europe: Contrast Agents Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 50 Europe: Contrast Agents Market Size, By Indication, 2014-2021 (USD Million)
Table 51 Europe: Contrast Agents Market Size, By Application, 2014-2021 (USD Million)
Table 52 Indicative List of Upcoming Events in Europe
Table 53 Europe 5: Contrast Agents Market Size, By Procedure, 2014-2021 (USD Million)
Table 54 Europe 5: Contrast Agents Market Size, By Type, 2014-2021 (USD Million)
Table 55 Europe 5: Contrast Agents Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 56 Europe 5: Contrast Agents Market Size, By Indication, 2014-2021 (USD Million)
Table 57 Europe 5: Contrast Agents Market Size, By Application, 2014-2021 (USD Million)
Table 58 RoE: Contrast Agents Market Size, By Procedure, 2014-2021 (USD Million)
Table 59 RoE: Contrast Agents Market Size, By Type, 2014-2021 (USD Million)
Table 60 RoE: Contrast Agents Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 61 RoE: Contrast Agents Market Size, By Indication 2014-2021 (USD Million)
Table 62 RoE: Contrast Agents Market Size, By Application, 2014-2021 (USD Million)
Table 63 Research Projects in Asia-Pacific, 2013–2016
Table 64 APAC: Contrast Agents Market Size, By Procedure, 2014-2021 (USD Million)
Table 65 APAC: Contrast Agents Market Size, By Type, 2014-2021 (USD Million)
Table 66 APAC: Contrast Agents Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 67 APAC: Contrast Agents Market Size, By Indication 2014-2021 (USD Million)
Table 68 APAC: Contrast Agents Market Size, By Application, 2014-2021 (USD Million)
Table 69 RoW: Contrast Agents Market Size, By Procedure, 2014-2021 (USD Million)
Table 70 RoW: Contrast Agents Market Size, By Type, 2014-2021 (USD Million)
Table 71 RoW: Contrast Agents Market Size, By Route of Administration, 2014-2021 (USD Million)
Table 72 RoW: Contrast Agents Market Size, By Indication 2014-2021 (USD Million)
Table 73 RoW: Contrast Media Market Size, By Application, 2014-2021 (USD Million)
Table 74 Market Developments (Product Approvals), 2013–2016
Table 75 Agreements, Collaborations, Contracts, and Partnerships, 2013–2016
Table 76 Expansions, 2013–2016
Table 77 Other Strategies, 2013–2016


List of Figures (41 Figures)

Figure 1 Research Methodology: Global Contrast Media/Contrast Agents Market
Figure 2 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Sampling Frame: Primary Research
Figure 4 Key Data From Primary Sources
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Research Design: Global Contrast Media/ Contrast Agents Market
Figure 8 Data Triangulation Methodology
Figure 9 Contrast Media/Contrast Agents Market, By Procedure (2016)
Figure 10 Contrast Media/Contrast Agents Market, By Route of Administration, 2016 vs 2021
Figure 11 Contrast Media/Contrast Agents Market, By Indication, 2016 vs 2021
Figure 12 Contrast Media/Contrast Agents Market Analysis, By Application, 2016 vs 2021
Figure 13 Europe is Slated to Witness the Highest Growth in the Contrast Media/Contrast Agents Market During the Forecast Period
Figure 14 North America to Account for the Largest Market Share in 2016
Figure 15 Iodinated Contrast Media Segment to Dominate the Market in 2016
Figure 16 Europe to Witness Highest Growth During the Forecast Period
Figure 17 Cardiovascular Disorders to Command the Largest Market Share in 2016
Figure 18 Drivers, Restraints, Opportunities, & Challenges
Figure 19 Clinical Trials for Contrast Media/Contrast Agents, By Phase
Figure 20 Clinical Trials for Contrast Media/Contrast Agents, By Indication (2013–2016)
Figure 21 Microbubble Contrast Media to Form the Fastest-Growing Segment During the Forecast Period
Figure 22 X-Ray/CT Accounts for the Largest Share of the Contrast Media Market
Figure 23 Injectable Contrast Media/Contrast Agents are the Largest and Fastest-Growing Segment in the Contrast Media/Contrast Agents Market, By Route of Administration
Figure 24 Cardiovascular Disorders to Dominate the Contrast Media Market
Figure 25 Radiology to Account for the Largest Share of the Contrast Media Market, By Application (2016)
Figure 26 North America Commanded the Largest Share of the Contrast Media Market
Figure 27 North America: Contrast Media Market Snapshot
Figure 28 Prevalence of Alzheimer's Disease in the U.S., By Age Group, 2015
Figure 29 Europe: Contrast Media Market Snapshot
Figure 30 Asia-Pacific: Contrast Media Market Snapshot
Figure 31 RoW: Contrast Media Market Snapshot
Figure 32 Global Contrast Media Market Share, By Key Player, 2015
Figure 33 Key Developments of the Prominent Players in the Contrast Media Market (2013-2016)
Figure 34 Market Developments (Product Approvals) Key Growth Strategy Adopted By Market Players From 2013 to 2016
Figure 35 Product Mix of the Prominent Players in the Contrast Media Market
Figure 36 GE Healthcare: Company Snapshot
Figure 37 Bayer Healthcare: Company Snapshot
Figure 38 Guerbet Group: Company Snapshot
Figure 39 Lantheus Medical Imaging: Company Snapshot
Figure 40 Daiichi Sankyo: Company Snapshot
Figure 41 Spago Nanomedical AB: Company Snapshot

【レポートのキーワード】

造影剤、ヨード系造影剤、ガドリニウム造影剤、バリウム造影剤、マイクロバブル、微小気泡、コントラスト剤、医療機器、X線装置、MRI装置、超音波装置、放射線医学

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[造影剤の世界市場予測(~2021年):ヨード系造影剤、ガドリニウム造影剤、バリウム造影剤、マイクロバブル]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆